Blue Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-18,381
Closed -$1.06M – 138
2026
Q2
$1.06M Buy
18,381
+3,627
+25% +$208K 0.67% 45
2026
Q1
$895K Buy
14,754
+2,001
+16% +$117K 0.58% 52
2025
Q4
$688K Buy
+12,753
New +$614K 0.49% 53

Other funds holding BMY

Blue Capital's BMY Position: Q3 2026 in Review

Blue Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 18,381 shares — an estimated $1.06M sold.

Blue Capital first reported a position in BMY in Q4 2025 and held it in 3 quarters. The position peaked at $1.06M in Q2 2026. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Blue Capital reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Blue Capital sold 18,381 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.06M.
  • Blue Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 3 quarters.
  • Blue Capital's Bristol-Myers Squibb position peaked at $1.06M in Q2 2026.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.